- Report
- February 2026
- 168 Pages
Global
From €4335EUR$4,850USD£3,747GBP
- Report
- August 2025
- 196 Pages
Global
From €3168EUR$3,545USD£2,739GBP
€3520EUR$3,939USD£3,044GBP
- Report
- August 2025
- 181 Pages
Global
From €3168EUR$3,545USD£2,739GBP
€3520EUR$3,939USD£3,044GBP
- Report
- March 2026
- 194 Pages
Global
From €5228EUR$5,850USD£4,520GBP
- Report
- March 2026
- 372 Pages
Global
From €5228EUR$5,850USD£4,520GBP
- Report
- August 2025
- 192 Pages
Global
From €3168EUR$3,545USD£2,739GBP
€3520EUR$3,939USD£3,044GBP
- Report
- August 2025
- 197 Pages
Global
From €3168EUR$3,545USD£2,739GBP
€3520EUR$3,939USD£3,044GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- December 2025
- 200 Pages
Global
From €7105EUR$7,950USD£6,143GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1117EUR$1,250USD£966GBP
- Report
- January 2026
- 117 Pages
Global
From €4245EUR$4,750USD£3,670GBP
- Report
- July 2025
- 350 Pages
Global
From €4423EUR$4,949USD£3,824GBP
- Report
- July 2024
- 150 Pages
Global
From €5318EUR$5,950USD£4,597GBP

Fibrinogen is a hematological drug used to treat bleeding disorders. It is a glycoprotein found in the blood that helps form a clot when a person is bleeding. Fibrinogen is produced in the liver and is essential for normal blood clotting. When a person has a deficiency of fibrinogen, they may experience excessive bleeding. Fibrinogen replacement therapy is used to treat this condition.
Fibrinogen replacement therapy is used to treat a variety of conditions, including congenital fibrinogen deficiency, acquired fibrinogen deficiency, and bleeding disorders. It is also used to treat bleeding associated with surgery, trauma, and childbirth.
The fibrinogen market is highly competitive, with several companies offering products for the treatment of bleeding disorders. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Shire. These companies offer a range of products, including fibrinogen concentrates, fibrinogen replacement therapies, and fibrinogen-based products. Show Less Read more